Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study

ABACUS study group, Aldo Morrone, Antonio Cristaudo

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study'. Together they form a unique fingerprint.

Medicine & Life Sciences